Form 4 Tracker
John M. Evans

Director, CEO · 5 filings · Latest: Oct 15, 2026

Beam Therapeutics Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
BEAM
John M. EvansDirector, CEOOct 16, 2026
Sale
$23.9825,000$599.6K1,047,205
BEAM
John M. EvansDirector, CEOOct 16, 2026
Option Exercise
$1.0325,000$25.8K1,072,205
BEAM
John M. EvansDirector, CEOOct 15, 2026
Sale
$23.5725,000$589.1K1,047,205
BEAM
John M. EvansDirector, CEOOct 15, 2026
Option Exercise
$1.0325,000$25.8K1,072,205
BEAM
JOHN M EVANS—Oct 16, 2026
Proposed Sale
$23.9825,000$599.6K—
BEAM
JOHN M EVANS—Oct 15, 2026
Proposed Sale
$23.5725,000$589.1K—
BEAM
John M. EvansDirector, CEOJun 30, 2026
Sale
$34.3125,000$857.7K1,047,205
BEAM
John M. EvansDirector, CEOJun 30, 2026
Option Exercise
$1.0325,000$25.8K1,072,205
BEAM
John M. EvansDirector, CEOJun 29, 2026
Sale
$35.4925,000$887.4K1,047,205
BEAM
John M. EvansDirector, CEOJun 29, 2026
Option Exercise
$0.761325,000$19.0K1,072,205
BEAM
JOHN M EVANS—Jun 30, 2026
Proposed Sale
$34.3125,000$857.7K—
BEAM
JOHN M EVANS—Jun 29, 2026
Proposed Sale
$35.4925,000$887.4K—
BEAM
John M. EvansDirector, CEOApr 1, 2026
Sale
$24.5830,078$739.3K1,047,205
BEAM
John M. EvansDirector, CEOMar 31, 2026
Sale
$22.7625,000$569.1K986,667
BEAM
John M. EvansDirector, CEOMar 31, 2026
Option Exercise
$0.6725,000$16.8K1,011,667
BEAM
John M. EvansDirector, CEOMar 30, 2026
Sale
$22.3725,000$559.2K986,667
BEAM
John M. EvansDirector, CEOMar 30, 2026
Option Exercise
$0.6725,000$16.8K1,011,667
BEAM
JOHN M. EVANS—Apr 2, 2026
Proposed Sale
$21.9066,874$1.5M—
BEAM
JOHN M EVANS—Mar 31, 2026
Proposed Sale
$22.7625,000$569.1K—
BEAM
JOHN M EVANS—Mar 30, 2026
Proposed Sale
$22.3725,000$559.2K—

Page 1 of 2

Next →